Published in
Elsevier, Clinical Lung Cancer, 4(18), p. e289-e296
DOI: 10.1016/j.cllc.2017.01.002
Links
Tools
Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non–Small-cell Lung Cancer: A TRAIL Trial
Journal article published in 2017 by
Cheol-Kyu Park 
,
In-Jae Oh ,
Kyu-Sik Kim,
Yoo-Duk Choi,
Tae-Won Jang,
Youn-Seup Kim,
Kwan-Ho Lee,
Kyeong-Cheol Shin,
Chi Young Jung ,
Sei-Hoon Yang,
Jeong-Seon Ryu,
Seung-Hun Jang,
Seung-Soo Yoo,
Suk-Joong Yong,
Kye Young Lee
and other authors.
,
In-Jae Oh ,
Kyu-Sik Kim,
Yoo-Duk Choi,
Tae-Won Jang,
Youn-Seup Kim,
Kwan-Ho Lee,
Kyeong-Cheol Shin,
Chi Young Jung ,
Sei-Hoon Yang,
Jeong-Seon Ryu,
Seung-Hun Jang,
Seung-Soo Yoo,
Suk-Joong Yong,
Kye Young Lee
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 